PETER BAYDU: Open Payments
NPI 1851961031 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 14 payments from 7 companies in 2025. Trend: 2023 $192 · 2024 $355 · 2025 $715
Food & beverage: $418Education: $297
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $202 |
| Janssen Biotech, Inc. | 7 | $196 |
| Daiichi Sankyo Inc. | 1 | $123 |
| SEAGEN INC. | 1 | $95 |
| SOBI, INC | 1 | $43 |
| Gilead Sciences, Inc. | 1 | $34 |
| Amgen Inc. | 1 | $21 |
Products named: Enhertu, RYBREVANT, Vonjo, Trodelvy, TECVAYLI, ERLEADA, DARZALEX, VECTIBIX.
Industry payments across TX — which companies pay providers there.
